Simon V.
- Country
- France
- Department
- Service de Néphrologie
Research Overview
- A Phase 3 open-label, controlled, randomised, multi-centre trial comparing imlifidase and standard-of-care with standard-of-care alone in the treatment of severe anti-GBM antibody disease (Goodpasture disease)
- Effect of Orforglipron on Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
- Phase 2 Open‑Label Study of Subcutaneous Surovatamig (AZD0486) in Adults with Antibody‑Mediated Kidney Disease: Safety, Tolerability, PK and Proteinuria Efficacy
Data & Insights
Has run more than one trial at 197 of 634 partner sites.
Specializations
Kidney Transplantation Research
Specializes in innovative therapeutic approaches for kidney transplant recipients, with particular focus on post-transplant complications and immunosuppression management.
- Calcineurin inhibitor optimization
- EBV-related complications prevention
- BK virus infection management
Investigates novel immunosuppressive strategies including belatacept and rituximab protocols.
Glomerular Diseases
Focuses on treating complex glomerular disorders through targeted therapeutic interventions.
- IgA Nephropathy treatment innovations
- Lupus nephritis management
- Anti-GBM disease interventions
Explores novel agents including ravulizumab and iptacopan for glomerulonephritis treatment.
Chronic Kidney Disease Management
Specializes in developing therapeutic strategies for chronic kidney disease with associated complications.
- Hypertension management in CKD
- Proteinuria reduction strategies
- Renal function preservation
Investigates combination therapies including baxdrostat and dapagliflozin for improved outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.